Status: Recruiting
BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)
The primary objective of the study is to confirm safety and technical success of BioPearl™ microspheres loaded with Doxorubicin in the treatment of unresectable hepatocellular carcinoma (HCC). The secondary objective of the study is to investigate the efficacy of BioPearl™ microspheres loaded with Doxorubicin in the treatment of subjects with unresectable HCC.
Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Terumo Europe N.V.Updated: Jan 22, 2025Locations: 10
Eligibility criteria
Subject is at least 18 years old [+13]
Subject previously treated with any systemic therapy for HCC [+12]